Alliancebernstein L.P. Moon Lake Immunotherapeutics Transaction History
Alliancebernstein L.P.
- $280 Billion
- Q4 2024
A detailed history of Alliancebernstein L.P. transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Alliancebernstein L.P. holds 1,022,604 shares of MLTX stock, worth $36.8 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,022,604
Previous 998,140
2.45%
Holding current value
$36.8 Million
Previous $50.3 Million
7.98%
% of portfolio
0.02%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding MLTX
# of Institutions
136Shares Held
58MCall Options Held
124KPut Options Held
96.9K-
Bvf Inc San Francisco, CA19.8MShares$710 Million39.28% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$305 Million35.64% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.34MShares$120 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$99.6 Million2.15% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.19MShares$78.6 Million0.02% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.33B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...